Wikidata

(Q36596646)

English

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis

scientific article published on September 2006

In more languages

Statements

title
Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017
author name string
Quan V Doan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017
Chiun-Fang Chiou
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017
Robert W Dubois
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017
publication date
1 September 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017
page(s)
555-569
1 reference
stated in
Europe PubMed Central
PubMed ID
16981801
retrieved
15 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q36596646&oldid=1640158364"